Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis.

Nasim Nehzat Omid Mirmosayyeb Mahdi Barzegar Reza Vosoughi Erfane Fazeli Vahid Shayegannejad

Published in: Neurology research international (2021)

Based on our findings, DMF is as efficacious and safe as TRF for the treatment of RRMS in our Iranian study population. Multicentric studies need to corroborate these findings in other populations.

Keyphrases

multiple sclerosis
white matter
systemic lupus erythematosus
replacement therapy